Physician profile
Lan Q Ly
NPI 1821404807
$1,098.07
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $301 · 2021: $96.39 · 2022: $293 · 2023: $73.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $73.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $73.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $311.69 | 2019-2023 | Trulicity, Mounjaro |
| Janssen Pharmaceuticals, INC | $114.35 | 2019-2022 | |
| Novo Nordisk INC | $103.19 | 2019-2022 | |
| Abbvie INC. | $91.24 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.19 | 2019-2023 | Synjardy, Jardiance |
| Amgen INC. | $75.60 | 2019-2020 | |
| Pfizer INC. | $58.37 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $58.35 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $45.23 | 2020-2022 | |
| Amarin Pharma, INC. | $41.25 | 2020-2022 | |
| Nevro Corp. | $24.41 | 2022 | |
| Integra Lifesciences Corporation | $18.79 | 2020 | |
| Exact Sciences Corporation | $15.52 | 2023 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $15.39 | 2022 | |
| Mylan Specialty L.P. | $14.25 | 2023 | Yupelri |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $12.98 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lan Ly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.